Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication ; volume:13 ; number:1 ; day:15 ; month:1 ; year:2013 ; pages:1-7 ; date:12.2013
BMC psychiatry ; 13, Heft 1 (15.1.2013), 1-7, 12.2013
- Creator
-
Wykes, Til
- Contributor
-
Rose, Diana
Williams, Paul
David, Anthony S.
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-13-28
- URN
-
urn:nbn:de:1111-2016081322744
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
07.08.2025, 1:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wykes, Til
- Rose, Diana
- Williams, Paul
- David, Anthony S.
- SpringerLink (Online service)
Other Objects (12)
Association Between Antipsychotic Medication Use and Diabetes
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
An explorative study of school performance and antipsychotic medication
Antipsychotic medication use and fracture: a case–control study
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
The role of pharmacists in supporting service users to optimise antipsychotic medication
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection
Association Between Antipsychotic Medication Use and Diabetes
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
An explorative study of school performance and antipsychotic medication
Antipsychotic medication use and fracture: a case–control study
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
The role of pharmacists in supporting service users to optimise antipsychotic medication
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection
Association Between Antipsychotic Medication Use and Diabetes
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
An explorative study of school performance and antipsychotic medication
Antipsychotic medication use and fracture: a case–control study
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
The role of pharmacists in supporting service users to optimise antipsychotic medication
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication